Tweets

December 11

This is escalating ... https://t.co/6t5mzikWwa

December 11

Injunction decision against US company in China causes share price fall and underlines dangers in country's emergin… https://t.co/Udm2svMHEA

December 09

Yesterday’s UK/EU Brexit deal may make it easier for the UK to be part of the UPC system after it leaves the EU. Th… https://t.co/TJnpcKW31x

Blog

11 Dec 2017
Surprise China injunction sends US company’s stock falling in semiconductor showdown

In a patent dispute that seems tailor-made for the Trump era, a US semiconductor company says a Chinese competitor has relied on IP infringement and government subsidies to significantly undercut its business. But although New York-based Veeco won a key preliminary injunction battle in front of a US district judge last month, a court in China hit the US company with an injunction of its own...

08 Dec 2017
After merger approach fails Sprint turns to infringement suit against cable giant Charter

Sprint, the US’s fourth largest mobile company, has launched a patent infringement lawsuit against Charter alleging that the cable TV giant infringes on 11 patents relating to voice over packet (VoP) technology. The case was filed in Delaware district court earlier this month and marks the latest attempt by Sprint, which is owned by Japanese tech giant Softbank, to monetise its...

08 Dec 2017
Novartis’ former IP chief urges innovative pharma to emulate high-tech patent strategies

The former global head of pharma intellectual property at Novartis has told IAM that life sciences companies should consider a more tech-like approach to IP management, involving licensing out development patents to competitors, rather than seeking to maintain market exclusivity on all incremental innovations. As well as making increasing commercial sense, such a strategy, he suggested, could...

Explore the current issue

Tech transfer in China: common mistakes and how to avoid them

The road to success is seldom straightforward when it comes to China technology deals. Having a thorough understanding of China’s innovation policies, technology import regulations and antitrust laws is crucial when it comes to avoiding missteps
Jiwen Chen

The world's leading patent professionals

IAM Patent 1000

The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.

Visit site

The world's leading IP strategists

IAM Strategy 300

A directory of individuals identified following a detailed research process as global leaders in providing IP value creation expertise to rights owners.

Visit site
IAM Market
Market intelligence

Market intelligence

Annual IAM supplements and management reports that take an in-depth look at specific areas of IP value creation concern and opportunity.

Visit site
IPBC

IPBC

Unique in the global IP marketplace, IPBC events bring together corporate leaders, aggregators, investors and other intermediaries to discuss key issues, network and do deals.

Visit site
IP Hall of Fame

IP Hall of Fame

A project designed to recognise the outstanding contributions that individual men and women have made towards the creation of today’s global IP system.

Visit site
Upcoming event

Upcoming event

Pharma and Biotech IP Summit 2018
February 8 2018 - London 
IAM's second annual event for senior patent executives in the life sciences industry. 
 

View all events
Subscribe

Subscribe

IAM is a unique publication which focuses on the many ways in which intellectual property and intangible assets can be used to create corporate value.

Subscribe now
International reports

International reports

Weekly updates from IAM’s team of international correspondents looking at recent developments in IP law and practice, business and finance.

Visit site